There are approximately 10,000 thoroughbred yearlings sold annually at high end sales in Kentucky. Breeders face significant risk that their yearlings will not qualify for sale due to two joint conditions: Osteochondrosis Dissecans (OCD) and Sesamoiditis.

This technology provides benefit to a horses overall health and healing by reducing cellular oxidative stress through a proprietary technology.  Huge potential market application and margins.  Information memorandum is underway.  Email for more information.